Ma, Y., Joyce, A., Brandenburg, O., Saatchi, F., Stevens, C., Toffessi Tcheuyap, V., . . . Brugarolas, J. (2022). HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans. Clinical cancer research, 28(24), 5405. https://doi.org/10.1158/1078-0432.CCR-22-0963
Citace podle Chicago (17th ed.)Ma, Yuanqing, et al. "HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans." Clinical Cancer Research 28, no. 24 (2022): 5405. https://doi.org/10.1158/1078-0432.CCR-22-0963.
Citace podle MLA (9th ed.)Ma, Yuanqing, et al. "HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans." Clinical Cancer Research, vol. 28, no. 24, 2022, p. 5405, https://doi.org/10.1158/1078-0432.CCR-22-0963.